Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells

Published:2011-03-16 Issue:2 Volume:8 Page:520-531
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Cruz Luis J.¹,Tacken Paul J.¹,Bonetto Fernando¹,Buschow Sonja I.¹,Croes Huib J.²,Wijers Mietske²,de Vries I. Jolanda¹,Figdor Carl G.¹

Affiliation:

1. Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, University Medical Centre, Nijmegen, The Netherlands

2. Department of Cell Biology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp100356k

Reference41 articles.

1. Dendritic cell vaccines in melanoma: From promise to proof?

2. Migration of dendritic cell based cancer vaccines: in vivo veritas?

3. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

4. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Functional Microcapsule based on Monodisperse Short PEG Amphiphile for Drug Encapsulation and Protein Affinity Controlled Release;Chemistry – An Asian Journal;2024-04-11

2. Dendritic cell-targeting polymer nanoparticle-based immunotherapy for cancer: A review;International Journal of Pharmaceutics;2023-03

3. Emerging Biomaterials Imaging Antitumor Immune Response;Advanced Materials;2022-09-18

4. Nanomaterials and Advances in Tumor Immune-Related Therapy: A Bibliometric Analysis;Journal of Biomedical Nanotechnology;2022-09-01

5. Paclitaxel and Lapatinib dual loaded chitosan-coated PLGA nanoparticles enhance cytotoxicity by circumventing MDR1-mediated trastuzumab resistance in HER2 positive breast cancers: In-vitro and in-vivo studies;Journal of Drug Delivery Science and Technology;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3